Literature DB >> 9715760

Ventilatory inefficiency for carbon dioxide during exercise in patients with pulmonary hypertension.

T Reybrouck1, L Mertens, I Schulze-Neick, I Austenat, B Eyskens, M Dumoulin, M Gewillig.   

Abstract

The purpose of this study was to analyse the ventilatory efficiency for carbon dioxide (CO2) in the assessment of exercise tolerance in patients with pulmonary hypertension. Two groups of patients were studied. One group consisted of 37 patients with normal pulmonary artery pressure who underwent surgical closure of a left-to-right shunt. Another group was composed of 10 patients with pulmonary hypertension. Both patient groups were compared with the mean value of an age-matched pool of normal control subjects. Aerobic exercise performance was assessed by determination of the ventilatory threshold. The ventilatory efficiency for CO2 was assessed by calculating the slope of ventilation over carbon dioxide below the ventilatory threshold. The slope of ventilation vs. carbon dioxide output in patients with pulmonary hypertension (48 +/- 12) was steeper than the slope (31.3 +/- 7.0) in patients with normal pulmonary artery pressure (P < 0.05). Significant correlations (P < 0.05) were found between the pulmonary artery pressure and the slope of pulmonary ventilation over carbon dioxide (r = 0.92) and also with the physiological dead space-tidal volume ratio at maximal exercise (r = 0.55). This was associated with a severe reduction in exercise performance in patients with pulmonary hypertension, whereas in patients with normal pulmonary artery pressure it was only slightly below the lower limit of normal. These results demonstrate that patients with pulmonary hypertension have an inefficient ventilatory response to metabolically produced CO2 during exercise, which severely limits exercise tolerance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715760     DOI: 10.1046/j.1365-2281.1998.00109.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  9 in total

Review 1.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension.

Authors:  Paul R Woods; Bryan J Taylor; Robert P Frantz; Bruce D Johnson
Journal:  Am J Cardiol       Date:  2012-01-14       Impact factor: 2.778

3.  The usefulness of submaximal exercise gas exchange to define pulmonary arterial hypertension.

Authors:  Paul R Woods; Robert P Frantz; Bryan J Taylor; Thomas P Olson; Bruce D Johnson
Journal:  J Heart Lung Transplant       Date:  2011-05-31       Impact factor: 10.247

4.  Exercise Capacity and Quality of Life in Pulmonary Arterial Hypertension.

Authors:  Ling-Wei Chen; Ssu-Yuan Chen; Hsao-Hsun Hsu; Yen-Wen Wu; Yu-Mei Lai; Meng-Yueh Chien
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

5.  Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension.

Authors:  Martin Schwaiblmair; Christian Faul; Wolfgang von Scheidt; Thomas M Berghaus
Journal:  BMC Pulm Med       Date:  2012-06-07       Impact factor: 3.317

6.  Exercise intolerance in pulmonary arterial hypertension.

Authors:  Robin M Fowler; Kevin R Gain; Eli Gabbay
Journal:  Pulm Med       Date:  2012-06-10

Review 7.  Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

Authors:  Denis E O'Donnell; Amany F Elbehairy; Danilo C Berton; Nicolle J Domnik; J Alberto Neder
Journal:  Front Physiol       Date:  2017-02-22       Impact factor: 4.566

8.  Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients.

Authors:  Eva L Peters; Jasmijn S J A van Campen; Herman Groepenhoff; Frances S de Man; Anton Vonk Noordegraaf; Harm J Bogaard
Journal:  Pulm Circ       Date:  2021-12-13       Impact factor: 3.017

9.  Pulmonary function differences in patients with chronic right heart failure secondary to pulmonary arterial hypertension and chronic left heart failure.

Authors:  Wei-Hua Liu; Qin Luo; Zhi-Hong Liu; Qing Zhao; Qun-Ying Xi; Hai-Feng Xue; Zhi-Hui Zhao
Journal:  Med Sci Monit       Date:  2014-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.